Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth, UK Facility

This significant milestone demonstrates the facility’s advanced capabilities, operational efficiency, and technical expertise. With this achievement, Piramal strengthens its leadership position in delivering critical bioconjugate therapies to patients in need. MUMBAI, India, March 16, 2026 — Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part…

Stock Market Developments & Insights

On March 16, 2026, the stock market displayed mixed outcomes with key indices showing diverse performances. The Dow Jones Industrial Average experienced a slight decrease, while the S&P 500 saw a moderate rise. This disparity was chiefly propelled by differing performances across various sectors.In particular, the technology sector exhibited resilience…

Hello IP Reshapes Content Marketing Through a Creator-Driven Distribution Model

The Singapore-headquartered platform helps brands improve content reach and conversion in the era of short-form video and interest-based e-commerce. SINGAPORE – March 16, 2026 – (SeaPRwire) – As short-form video continues to reshape how information spreads and how consumers engage with brands, efficient collaboration between brands and creators has become increasingly important. Hello…

Chia Tai Enterprises International Proposes Name Change to CPBIO Biotech is the Core Growth Engine: Innovation Fuels Diversified Portfolio

EQS via SeaPRwire.com / 16/03/2026 / 19:20 UTC+8 Chia Tai Enterprises International Proposes Name Change to CPBIO Biotech is the Core Growth Engine: Innovation Fuels Diversified Portfolio   (16 March 2026 – Hong Kong) Chia Tai Enterprises International Limited (Stock Code: 03839.HK) is pleased to announce today that it proposes…

Major Milestone CF PHARMTECH, INC. 2652.HK Announces IND Acceptance for PAH New Drug with a Globally Innovative Improved Mechanism, Marking Another Milestone for Its Precision Drug Delivery Platform

EQS via SeaPRwire.com / 16/03/2026 / 18:08 UTC+8 Focused on developing high-value inhalation therapies for pulmonary hypertension (PAH and PH-ILD), with clinical potential to expand into pulmonary fibrosis indications (PF-ILD, including IPF and PPF). Suzhou, China, March 13, 2026 — CF PHARMTECH, INC. (HKEX: 2652.HK, hereinafter referred to as “CF…

Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category)

TOKYO, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy Japan Ltd. has been recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) under the recognition program, jointly administered by Japan’s Ministry of Economy, Trade and Industry (METI) and Nippon Kenko Kaigi (Japan Health…

China Lilang Announces 2025 Annual Results

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – China Lilang Limited (“China Lilang” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1234) today announced its results for the year 2025.Mr. Wang Dong Xing, Chairman and Non-Executive Director of China Lilang, said: “In 2025, against…

Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management

Kawasaki and Tokyo, Japan, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Japan Limited and Teikyo University Hospital today announced the start of a joint proof of concept aimed at strengthening regional medical collaboration. The initiative, which commenced on March 16, focuses on developing new information analysis and…